CCDRD AG started a multicentric, multinational dose-finding trial with the biotech drug G-CSF. The patients are being recruited in 5 countries in Europe and Asia.
Phase II trial, multinational
Dose-finding study
Non-Hodgkin´s Lymphoma patients
CCDRD AG started a multicentric, multinational dose-finding trial with the biotech drug G-CSF. The patients are being recruited in 5 countries in Europe and Asia.
Phase II trial, multinational
Dose-finding study
Non-Hodgkin´s Lymphoma patients